Active B-Complex
Active B-Complex, licence 80093793: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- GNA Naturals Inc.
- NPN or DIN-HM
- 80093793
- Status
- Active licence
- Licence date
- 8 August 2019
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 50 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 50 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Niacinamide Source : Niacinamide | 50.0 milligramme | Not calculated |
| Biotine Source : Biotine | 250.0 microgrammes | Not calculated |
| Folate Source : L-5 Méthyltétrahydrofolate, sel de calcium | 400.0 microgrammes | Not calculated |
| Acide para-aminobenzoïque Source : Acide para-aminobenzoïque | 25.0 milligramme | Not calculated |
| Vitamine B6 Source : Pyridoxal 5'-phosphate | 25.0 milligramme | 50,000 µg |
Non-medicinal ingredients
Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
A factor in the maintenance of good health . Helps to maintain healthy hair, nail, mucous membranes and/or skin. Helps to maintain the body's ability to metabolize nutrients. Helps to form red blood cells. Helps to support normal early development of the fetal brain and spinal cord. Helps to reduce the risk of neural tube defects when taken daily at least three months prior to becoming pregnant and during early pregnancy. Helps normal growth and development. Helps in energy metabolism and tissue formation. A factor in the maintenance of good health and normal growth and development. Helps to maintain healthy mucous membranes. Helps to maintain normal metabolism of iron. Helps in energy production. Supports energy production. Helps to support liver function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Stop use if hypersensitivity occurs. People sensitive to nicotinic acid may experience flushing of the skin that is generally mild and transient.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a healthcare practitioner prior to use if you are taking sulfonamides.
Source
Official Health Canada record, licence 80093793
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.